To the best of our knowledge, our study, for the first time, prepared ILs encapsulating a small quantity of the highly potent cytotoxin TNM A, showing superior selectivity against HER2‐positive breast cancer cells at single‐digit nanomolar concentrations (Figure 2). Here, ERBB2 is linked to breast cancer.